critical limb ischemia

Latest Headlines

Latest Headlines

Aastrom lands a new CEO in a game of musical biotech chairs

Shares of Aastrom bounced higher yesterday as biotech veteran Dominick Colangelo was named the new CEO, taking the reins during a crucial pivotal study of the company's personalized cell therapy.

Angioplasty with nitinol stents shows promise as PAD treatment

Percutaneous transluminal angioplasty with nitinol stenting offers promise as a treatment for peripheral artery disease or critical limb ischemia, according to results of a new trial published in Catheterization and Cardiovascular Interventions, a Wiley journal published on behalf of the Society for Cardiovascular Angiography and Interventions.

Juventas snags $22M B round for mid-stage stem cell program

More than a year after flagging its interest in a B round, Cleveland Clinic-spinout Juventas Therapeutics has put the final pieces together for a $22.2 million raise.

Cook Medical bankrolls trial for PAD complication surgical procedure

Cook Medical is backing a new clinical study designed to test a new endovascular treatment in as many as 200 patients to address a major complication associated with peripheral artery disease that can lead to leg amputation.

Aastrom banks $38M for pivotal study of cellular therapy

Aastrom Biosciences' ($ASTM) stock was up this morning after the developer announced a $40 million financing deal with Eastern Capital.